Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Other financing activities (2016 - 2025)

Historic Other financing activities for Acadia Healthcare Company (ACHC) over the last 15 years, with Q1 2025 value amounting to $18.6 million.

  • Acadia Healthcare Company's Other financing activities rose 71644.74% to $18.6 million in Q1 2025 from the same period last year, while for Sep 2025 it was $20.3 million, marking a year-over-year increase of 41772.96%. This contributed to the annual value of $5.2 million for FY2024, which is 7511.83% up from last year.
  • Latest data reveals that Acadia Healthcare Company reported Other financing activities of $18.6 million as of Q1 2025, which was up 71644.74% from $1.7 million recorded in Q4 2024.
  • Acadia Healthcare Company's Other financing activities' 5-year high stood at $18.6 million during Q1 2025, with a 5-year trough of -$2.0 million in Q2 2021.
  • Over the past 5 years, Acadia Healthcare Company's median Other financing activities value was $1.7 million (recorded in 2024), while the average stood at $3.3 million.
  • Its Other financing activities has fluctuated over the past 5 years, first crashed by 11741.94% in 2021, then surged by 230909.09% in 2024.
  • Acadia Healthcare Company's Other financing activities (Quarter) stood at -$2.0 million in 2021, then surged by 210.81% to $2.2 million in 2022, then crashed by 80.77% to $420000.0 in 2023, then soared by 300.0% to $1.7 million in 2024, then soared by 1008.04% to $18.6 million in 2025.
  • Its Other financing activities stands at $18.6 million for Q1 2025, versus $1.7 million for Q4 2024 and $530000.0 for Q3 2024.